Literature DB >> 11589778

Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria.

H Nahrevanian1, M J Dascombe.   

Abstract

The virulence of Plasmodia depends partly on the strain of parasite and partly on the host. In this study, Plasmodium berghei N/13/1A/4/203 caused the death of mice, whereas Plasmodium chabaudi chabaudi AS was not lethal. Current opinion is that nitric oxide (NO) and other reactive nitrogen intermediates (RNI) are produced in several host organs during malaria to resist infection or produce tissue damage. NO and RNI production in blood or plasma, brain, liver and spleen in MF1 mice was investigated during P. berghei and P. c. chabaudi infection, in order to help determine whether changes in NO production are beneficial or detrimental to the host in vivo. NO production was measured both directly and indirectly as nitrites and nitrates, to represent RNI. No changes in blood NO were detected in P. berghei infected mice, but increases were observed in brain, liver and spleen. In P. c. chabaudi infected mice, rises in NO concentration were observed in blood and spleen, whereas a decline in liver NO was seen, but there were no changes in brain. Liver contained the highest concentration of RNI, but increasing concentrations were seen in both plasma and spleen in both P. berghei and P. c. chabaudi infected mice. These results show that NO and RNI production alters during murine malaria. The changes depend upon the tissue, the day of infection, the degree of parasitaemia, the strain of Plasmodia and the method of measuring NO biosynthesis. Lethal P. berghei induced NO production in the mid and late stages of infection in mice when parasitaemia was high, whereas in nonlethal P. c. chabaudi infection, NO production was increased in the early and late stages when parasitaemia was low. These data are consistent with a role for NO in the protection of the MF1 mouse against Plasmodia. Failure to clear the parasite is associated with evidence of increased NO production in brain and liver, which may contribute to the pathology of malaria, but this hypothesis requires confirmation from other experimental approaches.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11589778     DOI: 10.1046/j.1365-3024.2001.00406.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  16 in total

1.  Winner of the society for biomaterials young investigator award for the annual meeting of the society for biomaterials, April 11-14, 2018, Atlanta, GA: S-nitrosated poly(propylene sulfide) nanoparticles for enhanced nitric oxide delivery to lymphatic tissues.

Authors:  Alex Schudel; Lauren F Sestito; Susan N Thomas
Journal:  J Biomed Mater Res A       Date:  2018-03-05       Impact factor: 4.396

2.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

3.  LAP-like process as an immune mechanism downstream of IFN-γ in control of the human malaria Plasmodium vivax liver stage.

Authors:  Rachasak Boonhok; Nattawan Rachaphaew; Apisak Duangmanee; Pornpimol Chobson; Sittiporn Pattaradilokrat; Pongsak Utaisincharoen; Jetsumon Sattabongkot; Marisa Ponpuak
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

4.  Immunomodulatory and antiparasitic effects of garlic-arteether combination via nitric oxide pathway in Plasmodium berghei-infected mice.

Authors:  P G Vathsala; P Krishna Murthy
Journal:  J Parasit Dis       Date:  2019-09-24

5.  Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.

Authors:  Hossein Nahrevanian; Mana Najafzadeh; Reza Hajihosseini; Habib Nazem; Mahin Farahmand; Zahra Zamani
Journal:  Korean J Parasitol       Date:  2009-05-27       Impact factor: 1.341

6.  Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.

Authors:  Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Mary A Misukonis; Jocelyn R Saunders; Sri Suprianto; J Brice Weinberg; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  Drug treatment of malaria infections can reduce levels of protection transferred to offspring via maternal immunity.

Authors:  Vincent Staszewski; Sarah E Reece; Aidan J O'Donnell; Emma J A Cunningham
Journal:  Proc Biol Sci       Date:  2012-02-22       Impact factor: 5.349

8.  Nitric oxide contributes to learning and memory deficits observed in hypothyroid rats during neonatal and juvenile growth.

Authors:  Mahmoud Hosseini; Samaneh Sadat Dastghaib; Houshang Rafatpanah; Mosa Al-Reza Hadjzadeh; Hossein Nahrevanian; Ismaeil Farrokhi
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

9.  In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components.

Authors:  H Nahrevanian; B Esmaeili; M Kazemi; H Nazem; M Amini
Journal:  Iran J Parasitol       Date:  2010-03       Impact factor: 1.012

10.  Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide Immunomodulation.

Authors:  H Nahrevanian; M Jalalian; M Farahmand; M Assmar; Ar Esmaeili Rastaghi; M Sayyah
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.